Table 2.
Findings in patients undergoing surgery without HITHOC
| Patient | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| Age/sex | 21/M | 46/F | 60/M | 55/M |
| Surgery | EPP | EPP | EPP | EPP |
| Lung infiltration | No | Yes | Yes | Yes |
| Chest wall infiltration | No | No | No | No |
| Mediastinal pleura involvement | Yes | No | No | No |
| Mediastinal infiltration | No | No | No | No |
| Mediastinal lymph nodes dissected | No | Yes | Yes | Yes |
| Diaphragm resection | Yes | Yes | Yes | Yes |
| Pericardial resection | Yes | Yes | Yes | Yes |
| Operative time (min) | 540 | 500 | 480 | 470 |
| Intraoperative complication | Ventricular fibrillations | No | No | No |
| Postoperative ventilation | Yes | No | No | No |
| Grade 3–4 morbidity | No | No | No | No |
| 90-day mortality | Yes | No | No | No |
| Time since diagnosis (months) | 9 | 6 | 1 | 2 |
| Preoperative performance status | 1 | 1 | 1 | 1 |
| Histology | Non-seminoma germ cell tumor | Epitheloid | Epitheloid | Epitheloid |
| Prior chemotherapy/NACT | Yes | Yes | No | No |
| Adjuvant chemotherapy | No | No | Yes | Yes |
| Adjuvant radiotherapy | No | For recurrence | No | No |
| Follow-up (months) | 0 | 36 | 24 | 12 |
| Progression-free survival (months) | 0 | 24 | 24 | NA |
| Overall survival (months) | 0 | 36 | 24 | 18 |
| Site of recurrence/progression | Disease free | Mediastinal lymph nodes | Disease free | NA |
NA not available